tak 779 has been researched along with bms 806 in 2 studies
| Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (bms 806) | Trials (bms 806) | Recent Studies (post-2010) (bms 806) |
|---|---|---|---|---|---|
| 118 | 1 | 35 | 45 | 0 | 18 |
| Protein | Taxonomy | tak 779 (IC50) | bms 806 (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 9.7 | |
| Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 | Human immunodeficiency virus 1 | 8.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Ho, P; Huang, L; Lai, W; Li, Z; Montefiori, D | 1 |
| Maddon, PJ; Olson, WC | 1 |
1 review(s) available for tak 779 and bms 806
| Article | Year |
|---|---|
Resistance to HIV-1 entry inhibitors.
Topics: Amides; Anti-HIV Agents; Benzylamines; CD4 Immunoadhesins; Cyclams; Drug Resistance, Viral; Enfuvirtide; Heterocyclic Compounds; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Peptide Fragments; Piperazines; Quaternary Ammonium Compounds | 2003 |
1 other study(ies) available for tak 779 and bms 806
| Article | Year |
|---|---|
Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.
Topics: Animals; Anti-HIV Agents; Betulinic Acid; Cell Line; Chlorocebus aethiops; COS Cells; Drug Resistance, Viral; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Humans; Membrane Fusion; Microbial Sensitivity Tests; Models, Molecular; Pentacyclic Triterpenes; Peptide Fragments; Triterpenes | 2008 |